Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions.

Amico KR, Ramirez C, Caplan MR, Montgomery BE, Stewart J, Hodder S, Swaminathan S, Wang J, Darden-Tabb NY, McCauley M, Mayer KH, Wilkin T, Landovitz RJ, Gulick R, Adimora AA; HPTN 069/A5305 Study Team and HPTN Women at Risk Committee.

J Int AIDS Soc. 2019 Mar;22(3):e25247. doi: 10.1002/jia2.25247.

2.

Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.

Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, Tappero JW, Kiarie J, Ronald A, Mujugira A, Tumwesigye E, Were E, Irungu E, Baeten JM; Partners PrEP Study Team.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):313-322.

3.

Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.

Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, Leite IC, Freitas L, Martins LMS, Torres TS, Vasconcelos R, De Boni RB, Anderson PL, Liu A, Luz PM, Veloso VG; PrEP Brasil Study Team.

Lancet HIV. 2018 Mar;5(3):e136-e145. doi: 10.1016/S2352-3018(18)30008-0. Epub 2018 Feb 18.

PMID:
29467098
4.

Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.

Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM.

AIDS Behav. 2017 May;21(5):1361-1375. doi: 10.1007/s10461-016-1458-y.

5.

Current US Guidelines for Prescribing HIV Pre-Exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.

Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, Blackstock O, Taggart T, Kaplan C, Caldwell A, Kershaw TS.

J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002042. [Epub ahead of print]

PMID:
30973543
6.

Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.

Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, Irvin R, Sineath RC, Sanchez T, Sullivan PS, Buchbinder SP.

AIDS Patient Care STDS. 2014 Dec;28(12):622-7. doi: 10.1089/apc.2014.0195.

7.

Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.

Shrestha R, Copenhaver M.

Front Public Health. 2018 Jul 13;6:195. doi: 10.3389/fpubh.2018.00195. eCollection 2018.

8.

Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.

Govender EM, Mansoor LE, Abdool Karim Q.

AIDS Care. 2017 Jun;29(6):734-740. doi: 10.1080/09540121.2016.1248349. Epub 2016 Nov 1.

PMID:
27799005
9.

Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.

Vaccher S, Grulich A, McAllister J, Templeton DJ, Bloch M, McNulty A, Holden J, Poynten IM, Prestage G, Zablotska I; PRELUDE Study Team.

BMJ Open. 2016 Jun 20;6(6):e012179. doi: 10.1136/bmjopen-2016-012179. Erratum in: BMJ Open. 2016 Jun 27;6(6):e012179corr1.

10.

Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region.

Mullins TLK, Idoine CR, Zimet GD, Kahn JA.

J Adolesc Health. 2018 Dec 18. pii: S1054-139X(18)30761-4. doi: 10.1016/j.jadohealth.2018.10.300. [Epub ahead of print]

PMID:
30578115
11.
12.

Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.

Liu A, Coleman K, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Sullivan P, Hightow-Weidman L, Buchbinder S, Scott H.

JMIR Res Protoc. 2019 Jan 25;8(1):e10659. doi: 10.2196/10659.

13.

"Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.

Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, Bukusi EA, Baeten JM, Brown JM.

J Int AIDS Soc. 2016 Dec 12;19(1):21134. doi: 10.7448/IAS.19.1.21134. eCollection 2016.

14.

Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation.

Galindo GR, Walker JJ, Hazelton P, Lane T, Steward WT, Morin SF, Arnold EA.

Implement Sci. 2012 Nov 26;7:116. doi: 10.1186/1748-5908-7-116.

15.

Women want Pre-Exposure Prophylaxis but are Advised Against it by Their HIV-positive Counterparts.

Goparaju L, Experton LS, Praschan NC, Warren-Jeanpiere L, Young MA, Kassaye S.

J AIDS Clin Res. 2015 Nov;6(11):1-10.

16.

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.

Bekker LG, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, Marzinke MA, Hendrix CW, Anderson PL, Elharrar V, Stirratt M, Rooney JF, Piwowar-Manning E, Eshleman SH, McKinstry L, Li M, Dye BJ, Grant RM; HPTN 067 (ADAPT) study team.

Lancet HIV. 2018 Feb;5(2):e68-e78. doi: 10.1016/S2352-3018(17)30156-X. Epub 2017 Oct 3.

17.

Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial.

Ramsey SE, Ames EG, Brinkley-Rubinstein L, Teitelman AM, Clarke J, Kaplan C.

Addict Sci Clin Pract. 2019 Mar 4;14(1):8. doi: 10.1186/s13722-019-0137-5.

18.

A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.

Biello KB, Edeza A, Salhaney P, Biancarelli DL, Mimiaga MJ, Drainoni ML, Childs ES, Bazzi AR.

AIDS Care. 2019 Mar 1:1-7. doi: 10.1080/09540121.2019.1587356. [Epub ahead of print]

PMID:
30822103
19.

Social Networks and Its Impact on Women's Awareness, Interest, and Uptake of HIV Pre-exposure Prophylaxis (PrEP): Implications for Women Experiencing Intimate Partner Violence.

Willie TC, Stockman JK, Keene DE, Calabrese SK, Alexander KA, Kershaw TS.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):386-393. doi: 10.1097/QAI.0000000000001935.

PMID:
30570528
20.

Factors Associated with Use of Short-Term Pre-Exposure Prophylaxis for HIV Among Female Partners of Migrant Miners in Mozambique.

Falcao J, Zerbe A, Lahuerta M, Baggaley R, Ahoua L, DiMattei P, Morales F, Ramiro I, El-Sadr WM.

AIDS Patient Care STDS. 2017 Dec;31(12):528-534. doi: 10.1089/apc.2017.0179.

PMID:
29211515

Supplemental Content

Support Center